Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
9955
Beskrivning
Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
Nyckelord
Versioner (5)
- 2015-03-04 2015-03-04 -
- 2015-03-09 2015-03-09 -
- 2015-04-22 2015-04-22 -
- 2015-12-08 2015-12-08 -
- 2016-02-11 2016-02-11 -
Uppladdad den
9 mars 2015
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Similar models
Evaluation AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
CL Item
Induction I (1)
CL Item
Induction II (optional) (2)
CL Item
Consolidation I (3)
CL Item
Consolidation II (4)
CL Item
Consolidation III (5)
CL Item
Consolidation IV (6)
CL Item
Maintenance (7)
CL Item
Follow-up (8)
CL Item
after 3 Months (3)
CL Item
after 6 Months (6)
CL Item
after 9 Months (9)
CL Item
after 12 Months (12)
Follow up number
Item
If Follow-up: consecutive Follow-up number
integer
C1704685 (UMLS CUI-1)
Status of patient
Item
Is the patient alive?
boolean
C3844896 (UMLS CUI-1)
Date of last information/death
Item
Date of last information/death
date
C1148348 (UMLS CUI-1)
C0011008 (UMLS CUI-2)
C1533716 (UMLS CUI-3)
C0011008 (UMLS CUI-2)
C1533716 (UMLS CUI-3)
CL Item
Leukemia (1)
CL Item
Infection (2)
CL Item
Bleeding (3)
CL Item
Secondary illness (4)
CL Item
Other (5)
CL Item
Unknown (6)
Specifiy if Cause of death = 2,4,5
Item
Specifiy if Cause of death = 2,4,5
text
Item Group
Response after Induction Cycles or Consolidation or Maintenance or during Follow-up
Date of evaluation
Item
Date of evaluation
date
C0220825 (UMLS CUI-1)
CL Item
CR (1)
CL Item
CRi (2)
CL Item
PR (3)
CL Item
RD (4)
CL Item
PD (5)
CL Item
ED (6)
CL Item
HD (7)
Extramedullary Manifestatation
Item
Extramedullary Manifestatation
boolean
C1517060 (UMLS CUI-1)
C1280464 (UMLS CUI-2)
C1280464 (UMLS CUI-2)
Extramedullary Manifestatation location
Item
Please specify Extramedullary Manifestation
text
Item Group
Evaluation based on on following examinations
Bone marrow evaluation done
Item
Bone marrow evaluation done (If yes specify on CRF "Bone marrow Evaluation"
boolean
C2238269 (UMLS CUI-1)
C1272695 (UMLS CUI-2)
C1272695 (UMLS CUI-2)
Blood count evaluation done
Item
Blood count evaluation done? (If yes specify on CRF "Blood Count Evaluation"
boolean
C0005771 (UMLS CUI-1)
C0022885 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C1272695 (UMLS CUI-4)
C0022885 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C1272695 (UMLS CUI-4)
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)